XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D307. A total of 7 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Noked Capital LTD | 198,888 | $871,000 | 0.20% |
Noked Israel Ltd | 198,888 | $871,000 | 0.20% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MORGAN STANLEY | 51,671 | $226,000 | 0.00% |
Citadel Advisors | 12,801 | $56,000 | 0.00% |
Renaissance Technologies | 22,280 | $98,000 | 0.00% |
UBS Group AG | 2,898 | $13,000 | 0.00% |